The launch of new production on the basis of the technology developed by P&M-Invest is one of the main activities of our company.
Within the framework of an establishment of Joint Venture between the Chinese company Qi-Chem and P&M-Invest at the present time there is Phentafluorophenol's technology development by the representatives of the company Qi-Chem the subsequent production of this product at factory in China. Learning new technologies developed by P&M-Invest is going on at the experimental site near Moscow.
Pentafluorophenol is the main starting material for the production of the drug Sofosbuvir, which is widely used for the treatment of hepatitis C worldwide. Due to the fact that the market consumption of this product is growing rapidly, the need for medical drug is large.
12 апреля 2017 05:33:00